Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | FGF13 |
| Upstream (Parents) |
|---|
| (<<) CNR2 → FGF13 |
| (<<) CNOT4 → FGF13 |
| (<<) STXBP5L → FGF13 |
| (<<) RBP1 → FGF13 |
| (<<) AMIGO2 → FGF13 |
| (<<) PRODH → FGF13 |
| (<<) KCNK1 → FGF13 |
| Downstream (Children) |
|---|
| FGF13 → CNR2 (>>) |
| FGF13 → ABI2 (>>) |
| FGF13 → FAM75A5///FAM75A3///FAM75A1///FAM75A4///FAM75A2///FAM75A6///FAM75A7 (>>) |
| FGF13 → STXBP5L (>>) |
| FGF13 → PLCB1 (>>) |
| FGF13 → RPL10P15///RPL10P8///RPL10P6///RPL10P16///RPL10 (>>) |
| FGF13 → PDE7B (>>) |
| FGF13 → ZNF821 (>>) |
| FGF13 → NGB (>>) |
| FGF13 → PRODH (>>) |
| FGF13 → HRK (>>) |
| FGF13 → UBA6 (>>) |
| FGF13 → A4GALT (>>) |
